VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Gilead Sciences, Inc. vs Nestle S.A.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Gilead Sciences, Inc.
GILD · NASDAQ Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Gilead Sciences, Inc.'s moat claims, evidence, and risks.
View GILD analysisNestle S.A.
NESN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Nestle S.A.'s moat claims, evidence, and risks.
View NESN analysisComparison highlights
- Moat score gap: Gilead Sciences, Inc. leads (74 / 100 vs 57 / 100 for Nestle S.A.).
- Segment focus: Gilead Sciences, Inc. has 5 segments (68.5% in HIV); Nestle S.A. has 7 segments (26.9% in Powdered and Liquid Beverages).
- Moat breadth: Gilead Sciences, Inc. has 8 moat types across 3 domains; Nestle S.A. has 6 across 3.
Primary market context
Gilead Sciences, Inc.
HIV
HIV treatment and prevention medicines (antiretroviral therapy and PrEP)
Global (U.S. and Europe are major markets)
Patients/prescribers; reimbursed by public and private payers; distributed via wholesalers and specialty pharmacies
Drug developer and marketing authorization holder
68.5%
Nestle S.A.
Powdered and Liquid Beverages
Packaged coffee (instant, roast and ground, portioned) and other powdered beverages (cocoa/malt, creamers)
Global
Consumers (end-users) via retail and e-commerce; plus out-of-home channels
Branded manufacturer and marketer; system operator for portioned coffee (machines + capsules)
26.9%
Side-by-side metrics
Moat coverage
Shared moat types
Gilead Sciences, Inc. strengths
Nestle S.A. strengths
Segment mix
Gilead Sciences, Inc. segments
Full profile >HIV
Oligopoly
Oncology (Cell Therapy + Trodelvy)
Oligopoly
Liver Disease
Oligopoly
Veklury (Remdesivir)
Competitive
Other Products
Competitive
Nestle S.A. segments
Full profile >Powdered and Liquid Beverages
Oligopoly
PetCare
Oligopoly
Nutrition and Health Science
Oligopoly
Prepared dishes and cooking aids
Competitive
Milk products and Ice cream
Competitive
Confectionery
Oligopoly
Water
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.